@article{10.1172/jci.insight.127889, author = {Ran Wei AND Xiang Ren AND Hongyu Kong AND Zhongping Lv AND Yongjiang Chen AND Yunjing Tang AND Yujiao Wang AND Lirong Xiao AND Tao Yu AND Sabiha Hacibekiroglu AND Chen Liang AND Andras Nagy AND Rod Bremner AND Danian Chen}, journal = {JCI Insight}, publisher = {The American Society for Clinical Investigation}, title = {Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma}, year = {2019}, month = {11}, volume = {4}, url = {https://insight.jci.org/articles/view/127889}, abstract = {Von Hippel–Lindau (Vhl) protein inhibits hypoxia-inducible factor (Hif), yet its deletion in murine retina does not cause the extensive angiogenesis expected with Hif induction. The mechanism is unclear. Here we show that retinoblastoma tumor suppressor (Rb1) constrains expression of Hif target genes in the Vhl–/– retina. Deleting Rb1 induced extensive retinal neovascularization and autophagic ablation of photoreceptors in the Vhl–/– retina. RNA-sequencing, ChIP, and reporter assays showed Rb1 recruitment to and repression of certain Hif target genes. Activating Rb1 by deleting cyclin D1 induced a partial defect in the retinal superficial vascular plexus. Unexpectedly, removing Vhl suppressed retinoblastoma formation in murine Rb1/Rbl1–deficient retina but generated subretinal vascular growths resembling retinal angiomatous proliferation (RAP) and retinal capillary hemangioblastoma (RCH). Most stromal cells in the RAP/RCH–like lesions were Sox9+, suggesting a Müller glia origin, and expressed Lgals3, a marker of human brain hemangioblastoma. Thus, the Rb family limit Hif target gene expression in the Vhl–/– retina, and removing this inhibitory signal generates new models for RAP and RCH.}, number = {22}, doi = {10.1172/jci.insight.127889}, url = {https://doi.org/10.1172/jci.insight.127889}, }